4DMedical Limited (4DX.AX)
- Previous Close
0.6000 - Open
0.6200 - Bid 0.6050 x --
- Ask 0.6100 x --
- Day's Range
0.5950 - 0.6250 - 52 Week Range
0.4500 - 1.2700 - Volume
352,556 - Avg. Volume
716,329 - Market Cap (intraday)
236.788M - Beta (5Y Monthly) 1.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date Feb 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.13
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
4dmedical.comRecent News: 4DX.AX
Performance Overview: 4DX.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4DX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4DX.AX
Valuation Measures
Market Cap
236.79M
Enterprise Value
193.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
347.86
Price/Book (mrq)
2.60
Enterprise Value/Revenue
328.56
Enterprise Value/EBITDA
-7.01
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-27.40%
Return on Equity (ttm)
-45.83%
Revenue (ttm)
1.03M
Net Income Avi to Common (ttm)
-30.83M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
47.88M
Total Debt/Equity (mrq)
5.00%
Levered Free Cash Flow (ttm)
-17.87M
Research Analysis: 4DX.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 4DX.AX
4DX.AX does not have Company Insights